These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 19821446

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Vitamin D compounds for people with chronic kidney disease requiring dialysis.
    Palmer SC, McGregor DO, Craig JC, Elder G, Macaskill P, Strippoli GF.
    Cochrane Database Syst Rev; 2009 Oct 07; (4):CD005633. PubMed ID: 19821349
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients.
    Ballinger AE, Palmer SC, Nistor I, Craig JC, Strippoli GF.
    Cochrane Database Syst Rev; 2014 Oct 07; 2014(12):CD006254. PubMed ID: 25490118
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antioxidants for chronic kidney disease.
    Jun M, Venkataraman V, Razavian M, Cooper B, Zoungas S, Ninomiya T, Webster AC, Perkovic V.
    Cochrane Database Syst Rev; 2012 Oct 17; 10(10):CD008176. PubMed ID: 23076940
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cinacalcet plus vitamin D versus vitamin D alone for the treatment of secondary hyperparathyroidism in patients undergoing dialysis: a meta-analysis of randomized controlled trials.
    Xu J, Yang Y, Ma L, Fu P, Peng H.
    Int Urol Nephrol; 2019 Nov 17; 51(11):2027-2036. PubMed ID: 31531805
    [Abstract] [Full Text] [Related]

  • 13. Interventions for preventing bone disease in kidney transplant recipients.
    Palmer SC, McGregor DO, Strippoli GF.
    Cochrane Database Syst Rev; 2007 Jul 18; (3):CD005015. PubMed ID: 17636784
    [Abstract] [Full Text] [Related]

  • 14. HMG CoA reductase inhibitors (statins) for dialysis patients.
    Navaneethan SD, Nigwekar SU, Perkovic V, Johnson DW, Craig JC, Strippoli GF.
    Cochrane Database Syst Rev; 2009 Apr 15; (2):CD004289. PubMed ID: 19370598
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mortality risk among hemodialysis patients receiving different vitamin D analogs.
    Tentori F, Hunt WC, Stidley CA, Rohrscheib MR, Bedrick EJ, Meyer KB, Johnson HK, Zager PG, Medical Directors of Dialysis Clinic Inc.
    Kidney Int; 2006 Nov 15; 70(10):1858-65. PubMed ID: 17021609
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Meta-analysis: vitamin D compounds in chronic kidney disease.
    Palmer SC, McGregor DO, Macaskill P, Craig JC, Elder GJ, Strippoli GF.
    Ann Intern Med; 2007 Dec 18; 147(12):840-53. PubMed ID: 18087055
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.